Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.

Hsu C, Ried LD, Bengtson MA, Garman PM, McConkey JR, Rahnavard F.

J Am Pharm Assoc (2003). 2008 May-Jun;48(3):393-400. doi: 10.1331/JAPhA.2008.07007.

PMID:
18595825
2.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

3.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

4.

Increased cardiovascular risk with second-generation antipsychotic agent switches.

Ried LD, Renner BT, McConkey JR, Bengtson MA, Lopez LM.

J Am Pharm Assoc (2003). 2006 Jul-Aug;46(4):491-8; quiz 499-501. Review.

PMID:
16913393
5.

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

Meyer JM, Koro CE.

Schizophr Res. 2004 Sep 1;70(1):1-17. Review.

PMID:
15246458
6.

Metabolic monitoring for patients treated with antipsychotic medications.

Cohn TA, Sernyak MJ.

Can J Psychiatry. 2006 Jul;51(8):492-501. Review.

PMID:
16933586
7.

The metabolic effects of antipsychotic medications.

Newcomer JW, Haupt DW.

Can J Psychiatry. 2006 Jul;51(8):480-91. Review.

PMID:
16933585
8.

Rethinking antipsychotic formulary policy.

Rosenheck RA, Leslie DL, Busch S, Rofman ES, Sernyak M.

Schizophr Bull. 2008 Mar;34(2):375-80. Epub 2007 Jul 18. Review.

9.

Addressing cardiometabolic risk during treatment with antipsychotic medications.

Amiel JM, Mangurian CV, Ganguli R, Newcomer JW.

Curr Opin Psychiatry. 2008 Nov;21(6):613-8. doi: 10.1097/YCO.0b013e328314b74b. Review.

10.

Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.

Hirsch L, Yang J, Bresee L, Jette N, Patten S, Pringsheim T.

Drug Saf. 2017 Jun 5. doi: 10.1007/s40264-017-0543-0. [Epub ahead of print] Review.

PMID:
28585153
11.

Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.

Spina E, Hiemke C, de Leon J.

Expert Opin Drug Metab Toxicol. 2016;12(4):407-22. doi: 10.1517/17425255.2016.1154043. Epub 2016 Feb 29. Review.

PMID:
26878495

Supplemental Content

Support Center